Association between Glasgow Coma Scale in Early Carbon Monoxide Poisoning and Development of Delayed Neurological Sequelae: A Meta-Analysis | Canada Hyperbarics Skip to main content
Meta-Analysis J Pers Med 2022

Association between Glasgow Coma Scale in Early Carbon Monoxide Poisoning and Development of Delayed Neurological Sequelae: A Meta-Analysis

Namgung M, Oh J, Ahn C, Kim C, Lee H, Kang H — J Pers Med, 2022

Tier 1, Curated

Manually reviewed and included in the Canada Hyperbarics research database.

Summary

What Researchers Did

Researchers conducted a meta-analysis of 10 studies involving 2328 patients to investigate if a low Glasgow Coma Scale (GCS) score in early carbon monoxide poisoning predicts the development of delayed neurological problems.

What They Found

Patients with a low GCS score after acute carbon monoxide poisoning had a significantly higher chance of developing delayed neurological problems, with an overall odds ratio of 2.98 (95% confidence interval 2.10-4.23). Specifically, those with a GCS score below 9 showed an odds ratio of 2.80 (95% CI 1.91-4.12) for developing these issues. For scores below 10 or 11, the odds ratio was even higher at 4.24 (95% CI 1.55-11.56), indicating a strong link between a lower initial GCS score and future neurological complications.

Canadian Relevance

Carbon monoxide poisoning is a Health Canada-recognised indication for hyperbaric oxygen therapy, making these findings relevant for patient care in Canada.

Study Limitations

As a meta-analysis, this study's findings are dependent on the quality and consistency of the original studies included, and moderate heterogeneity was observed.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Meta-Analysis
Category Neurological
Source Pubmed
PubMed ID 35455751
Year Published 2022
Journal J Pers Med

Cite This Study

Share
Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 17, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology